Research Programs at Fox Chase
00 / 00
Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Our oncology experts, who have been awarded two Nobel prizes, support today’s patients by investigating problems that range from understanding the fundamental biomolecular mechanisms of cancer all the way through to the treatment of many cancer types in the clinic. As one of the four original cancer centers to receive comprehensive cancer center designation from the National Cancer Institute (NCI), our interdisciplinary research programs couple discovery science with state-of-the-art clinical care and population health.
Fox Chase’s research efforts date back to 1926 with the founding of The Institute for Cancer Research, which joined the American Oncologic Hospital in 1974 to become Fox Chase Cancer Center. Our merger in 2012 with Temple University Health System’s oncology research, treatment and prevention programs has continued to expand our reach, incorporating additional expertise in molecular biology, cancer prevention and control and enabling collaboration with several key centers of excellence, including Temple’s Moulder Center for Drug Discovery Research.
Some of our significant discoveries and contributions include: